Clinical and Histological Outcomes of Using Collagen Matrix or Soft Tissue Graft Around Implants
NCT ID: NCT05123898
Last Updated: 2021-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2020-01-14
2021-11-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During the operation, incision was made along the top of the alveolar ridge within the defect; a full-thickness muco-periosteal flap was elevated. Traditional 2-stage dental implantation was performed according to surgical protocols of dental implant systems Ostem (Osstem Implant Co., Ltd., Korea; registration in Russia 05.09.2018 No FSZ 2018/7577). A free connective tissue graft was harvested in patients of the first group. Graft was fixed with a horizontal U-shaped suture to the buccal muco-periosteal flap. In second patients group a fragment of the collagen matrix "Fibromatrix" was fixed to the buccal muco-periosteal flap (LLC "Cardioplant", Russia; registration in Russia 20.05.2019 No № FSZ 2019/83671). For patients of all groups mobilization of the muco-periosteal flap conducted followed by suturing the wound tightly without tension with simple interrupted sutures.
In the early postoperative period the standard antibacterial and anti-inflammatory therapy in combination with the use of local antiseptics for daily care was prescribed. The stage of the implant uncovering with hilling abutments installation was carried out 3 months after the intervention. At this stage, a soft tissue fragment was taken using a mucotome in the area of the previously performed mucous membrane thickness increasing for subsequent histomorphometric analysis. In the study we used both conventional light microscopy (microscopy in the light field) and polarizing microscopy - to estimate the content of collagen fibers in preparations stained with picrosirius red. During a morphometric study we carried out a quantitative assessment of the characteristics of the epithelial layer, the basement membrane relative length (the ratio of the absolute length of the basement membrane to the length of the epithelial layer), the characteristics of the underlying connective tissue.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 group
The patients underwent implant placement in combination with an increase in the thickness of soft tissues using a free connective tissue graft from the tuber region on the upper jaw.
Soft tissue augmentation
1. Incision the mucosa at the alveolar ridge, mucosal-periosteal flap elevation
2. Placement of the Ostem dental implant (Osstem Implant Co., Ltd.)
3. Modeling of sterile collagen matrix according to the shape of the recipient bed
4. Fixation of the collagen matrix to the vestibular flap
5. Suturing the wound tightly
2 group
The patients underwent implant placement in combination with an increase in the thickness of soft tissues using collagen matrix "Fibromatrix"
Soft tissue augmentation
1. Incision the mucosa at the alveolar ridge, mucosal-periosteal flap elevation
2. Placement of the Ostem dental implant (Osstem Implant Co., Ltd.)
3. Modeling of sterile collagen matrix according to the shape of the recipient bed
4. Fixation of the collagen matrix to the vestibular flap
5. Suturing the wound tightly
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Soft tissue augmentation
1. Incision the mucosa at the alveolar ridge, mucosal-periosteal flap elevation
2. Placement of the Ostem dental implant (Osstem Implant Co., Ltd.)
3. Modeling of sterile collagen matrix according to the shape of the recipient bed
4. Fixation of the collagen matrix to the vestibular flap
5. Suturing the wound tightly
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The presence of an included defect (1 teeth) in the distal part of the lower jaw with a sufficient volume of bone tissue;
3. Deficiency of soft tissue thickness;
4. Adjacent teeth are without any of periodontal disease, namely the absence of periodontal probing depth \> 3 mm in any site of adjacent teeth;
6\. Satisfactory level of oral hygiene, namely full mouth plaque score \< 20% and full mouth bleeding score \< 20%;
1. The presence of concomitant pathology in the stage of decompensation;
2. Hard smokers (more than 10 cigarettes per day);
3. Radio and chemotherapy in history over the past 5 years;
4. Pregnancy and breastfeeding;
5. Taking medications that affect the healing of soft tissues (nonsteroidal anti-inflammatory drug, steroid drugs).
Exclusion Criteria
2. Pregnantcy following entrance into the study;
3. Patients having poor oral hygiene or not wanting to carry out oral hygiene measures;
4. Subjects, who in the opinion of the investigator, for any reason will not be able to complete the study per protocol.
21 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
I.M. Sechenov First Moscow State Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
I.M. Sechenov First Moscow State Medical University
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09102019
Identifier Type: -
Identifier Source: org_study_id